Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Cancer Research
|
August 1, 1986
Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer
R H Wheeler, H A Ziessman, B R Medvec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
Cancer Research
|
August 15, 1992
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma
M N Saleh, M B Khazaeli, R H Wheeler, et al.
Cancer Research
|
October 1, 1995
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer
M N Saleh, M B Khazaeli, R H Wheeler, et al.
Cancer Research
|
October 1, 1993
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer
M N Saleh, M B Khazaeli, W E Grizzle, et al.
Cancer Research
|
October 15, 1991
Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans
M B Khazaeli, M N Saleh, T P Liu, et al.
Human Antibodies and Hybridomas
|
October 1, 1993
Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer
R F Meredith, M B Khazaeli, W E Grizzle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease
R T Silver, D C Case, R H Wheeler, et al.
Human Antibodies and Hybridomas
|
January 1, 1992
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma
M N Saleh, M B Khazaeli, R H Wheeler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1994
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49
R F Meredith, A J Bueschen, M B Khazaeli, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Cancer Research
|
August 1, 1986
Tumor blood flow and systemic shunting in patients receiving intraarterial chemotherapy for head and neck cancer
R H Wheeler, H A Ziessman, B R Medvec, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1996
Phase II study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer
R F Meredith, M B Khazaeli, W E Plott, et al.
Cancer Research
|
August 15, 1992
Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma
M N Saleh, M B Khazaeli, R H Wheeler, et al.
Cancer Research
|
October 1, 1995
Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer
M N Saleh, M B Khazaeli, R H Wheeler, et al.
Cancer Research
|
October 1, 1993
A phase I clinical trial of murine monoclonal antibody D612 in patients with metastatic gastrointestinal cancer
M N Saleh, M B Khazaeli, W E Grizzle, et al.
Cancer Research
|
October 15, 1991
Pharmacokinetics and immune response of 131I-chimeric mouse/human B72.3 (human gamma 4) monoclonal antibody in humans
M B Khazaeli, M N Saleh, T P Liu, et al.
Human Antibodies and Hybridomas
|
October 1, 1993
Direct localization comparison of murine and chimeric B72.3 antibodies in patients with colon cancer
R F Meredith, M B Khazaeli, W E Grizzle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1991
Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease
R T Silver, D C Case, R H Wheeler, et al.
Human Antibodies and Hybridomas
|
January 1, 1992
Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma
M N Saleh, M B Khazaeli, R H Wheeler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
June 1, 1994
Treatment of metastatic prostate carcinoma with radiolabeled antibody CC49
R F Meredith, A J Bueschen, M B Khazaeli, et al.
Page
of 8